wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q39307416-30D2B271-581E-42AC-B5C2-5EE75969A5C4
Q39307416-30D2B271-581E-42AC-B5C2-5EE75969A5C4
BestRank
Statement
http://www.wikidata.org/entity/statement/Q39307416-30D2B271-581E-42AC-B5C2-5EE75969A5C4
Hepatocellular carcinoma treatment: a comparative review of emerging growth factor receptor antagonists.
P2860
Q39307416-30D2B271-581E-42AC-B5C2-5EE75969A5C4
BestRank
Statement
http://www.wikidata.org/entity/statement/Q39307416-30D2B271-581E-42AC-B5C2-5EE75969A5C4
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
78e30e6977b84db3119546d634c936fe0e3a6077
P2860
Brivanib in patients with advanced hepatocellular carcinoma who were intolerant to sorafenib or for whom sorafenib failed: results from the randomized phase III BRISK-PS study.